Recent studies have shown that depletion of FLCN specifically in the mouse liver protects mice from developing fibrosis and inflammation upon exposure to a non-alcoholic steatohepatitis (NASH)-inducing diet. Here, FLCN is linked to metabolic dysfunction-associated steatohepatitis.